{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T13:41:48Z","timestamp":1756993308570},"reference-count":0,"publisher":"American Society for Clinical Investigation","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Invest."],"published-print":{"date-parts":[[1955,2,1]]},"DOI":"10.1172\/jci103081","type":"journal-article","created":{"date-parts":[[2008,2,13]],"date-time":"2008-02-13T14:31:23Z","timestamp":1202913083000},"page":"277-284","source":"Crossref","is-referenced-by-count":26,"title":["THE EFFECT OF A SINGLE ORAL DOSE OF THE CARBONIC ANHYDRASE INHIBITOR, ACETAZOLEAMIDE, IN RENAL DISEASE"],"prefix":"10.1172","volume":"34","author":[{"given":"Michael","family":"Kaye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"232","container-title":["Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jci.org\/articles\/view\/103081\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T16:52:02Z","timestamp":1691081522000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jci.org\/articles\/view\/103081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1955,2,1]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1955,2,1]]}},"URL":"https:\/\/doi.org\/10.1172\/jci103081","relation":{},"ISSN":["0021-9738"],"issn-type":[{"value":"0021-9738","type":"print"}],"subject":[],"published":{"date-parts":[[1955,2,1]]}}}